Literature DB >> 28429991

Effects of medium-chain triglycerides on intestinal morphology and energy metabolism of intrauterine growth retarded weanling piglets.

Li-Li Zhang1, Hao Zhang1, Yue Li1, Tian Wang1.   

Abstract

It has been shown that there is a relationship between intrauterine growth retardation (IUGR) and postnatal intestinal damage involved in energy deficits. Therefore, the present study was conducted to investigate the effect of medium-chain triglycerides (MCT) on the intestinal morphology, intestinal function and energy metabolism of piglets with IUGR. At weaning (21 ± 1.1 d of age), 24 IUGR piglets and 24 normal birth weight (NBW) piglets were selected according to their birth weights (BW) (IUGR: 0.95 ± 0.04 kg BW; NBW: 1.58 ± 0.04 kg BW) and their weights at the time of weaning (IUGR: 5.26 ± 0.15 kg BW; NBW: 6.98 ± 0.19 kg BW). The piglets were fed a diet of either long-chain triglycerides (LCT) (containing 5% LCT) or MCT (containing 1% LCT and 4% MCT) for 28 d. Then, the piglets' intestinal morphology, biochemical parameters and mRNA abundance related to intestinal damage and energy metabolism were determined. IUGR was found to impair intestinal morphology, with evidence of decreased villus height and increased crypt depth; however, these negative effects of IUGR were ameliorated by MCT treatment. IUGR piglets showed compromised intestinal digestion and absorption functions when compared with NBW piglets. However, feeding MCT increased the maltase activity in the jejunum and alleviated IUGR-induced reductions in plasma d-xylose concentrations and jejunal sucrase activity. IUGR decreased the efficiency of the piglets' intestinal energy metabolism; however, piglets fed an MCT diet exhibited increased adenosine triphosphate (ATP) concentrations and ATP synthase F1 complex beta polypeptide expression, as well as decreased adenosine monophosphate-activated kinase alpha 1 expression in the jejunum of piglets. In addition, up-regulation of the piglets' citrate synthase and succinate dehydrogenase levels was found to occur following MCT treatment at both the activity and the transcriptional levels of the jejunum. Therefore, it can be postulated that MCT treatment has beneficial effects in alleviating IUGR-induced intestinal morphologic damage, which is associated with improved intestinal energy metabolism.

Entities:  

Keywords:  Enzyme activity; gene expression; growth retardation; intrauterine; medium chain triglycerides; piglets; small intestine

Mesh:

Substances:

Year:  2017        PMID: 28429991     DOI: 10.1080/1745039X.2017.1312812

Source DB:  PubMed          Journal:  Arch Anim Nutr        ISSN: 1477-2817            Impact factor:   2.242


  4 in total

1.  Characteristics of the gut microbiota colonization, inflammatory profile, and plasma metabolome in intrauterine growth restricted piglets during the first 12 hours after birth.

Authors:  Shimeng Huang; Na Li; Cong Liu; Tiantian Li; Wei Wang; Lili Jiang; Zhen Li; Dandan Han; Shiyu Tao; Junjun Wang
Journal:  J Microbiol       Date:  2019-06-11       Impact factor: 3.422

2.  Intrauterine growth restriction alters growth performance, plasma hormones, and small intestinal microbial communities in growing-finishing pigs.

Authors:  Liang Xiong; Jinming You; Wanghong Zhang; Qian Zhu; Francois Blachier; Yulong Yin; Xiangfeng Kong
Journal:  J Anim Sci Biotechnol       Date:  2020-08-19

3.  Docosahexaenoate-enriched fish oil and medium chain triglycerides shape the feline plasma lipidome and synergistically decrease circulating gut microbiome-derived putrefactive postbiotics.

Authors:  Matthew I Jackson; Dennis E Jewell
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

4.  Comparing the gastrointestinal barrier function between growth-retarded and normal yaks on the Qinghai-Tibetan Plateau.

Authors:  Jian Ma; Ali Mujtaba Shah; Zhisheng Wang; Rui Hu; Huawei Zou; Xueying Wang; Guang Cao; Quanhui Peng; Bai Xue; Lizhi Wang; Suonan Zhao; Xiangying Kong
Journal:  PeerJ       Date:  2020-09-03       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.